Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
D009597:4-Nitrophenylphosphatase / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D004347:Drug Interactions; D005475:Flupenthixol / Q000494:pharmacology*; D005476:Fluphenazine / Q000494:pharmacology*; D005609:Free Radicals; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology; D010761:Phosphorus Radioisotopes; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013053:Spectrophotometry; D013892:Thioxanthenes / Q000494:pharmacology*
D005609:Free Radicals; D010761:Phosphorus Radioisotopes; D013892:Thioxanthenes; D000255:Adenosine Triphosphate; D012964:Sodium; D009597:4-Nitrophenylphosphatase; D000251:Adenosine Triphosphatases; D005475:Flupenthixol; D008274:Magnesium; D011188:Potassium; D005476:Fluphenazine